185 related articles for article (PubMed ID: 34359969)
1. Trafficking to the Cell Surface of Amino Acid Transporter SLC6A14 Upregulated in Cancer Is Controlled by Phosphorylation of SEC24C Protein by AKT Kinase.
Kovalchuk V; Nałęcz KA
Cells; 2021 Jul; 10(7):. PubMed ID: 34359969
[TBL] [Abstract][Full Text] [Related]
2. Trafficking of the amino acid transporter B
Kovalchuk V; Samluk Ł; Juraszek B; Jurkiewicz-Trząska D; Sucic S; Freissmuth M; Nałęcz KA
Biochim Biophys Acta Mol Cell Res; 2019 Feb; 1866(2):252-263. PubMed ID: 30445147
[TBL] [Abstract][Full Text] [Related]
3. Amino Acid Transporter SLC6A14 (ATB
Nałęcz KA
Front Cell Dev Biol; 2020; 8():594464. PubMed ID: 33195271
[TBL] [Abstract][Full Text] [Related]
4. Amino acid transporter SLC6A14 depends on heat shock protein HSP90 in trafficking to the cell surface.
Rogala-Koziarska K; Samluk Ł; Nałęcz KA
Biochim Biophys Acta Mol Cell Res; 2019 Oct; 1866(10):1544-1555. PubMed ID: 31326539
[TBL] [Abstract][Full Text] [Related]
5. Regulation of SLC6A14 trafficking in breast cancer cells by heat shock protein HSP90β.
Połosak K; Papierniak-Wyglądała A; Nałęcz KA
Biochem Biophys Res Commun; 2022 Jul; 614():41-46. PubMed ID: 35569376
[TBL] [Abstract][Full Text] [Related]
6. A new class of endoplasmic reticulum export signal PhiXPhiXPhi for transmembrane proteins and its selective interaction with Sec24C.
Otsu W; Kurooka T; Otsuka Y; Sato K; Inaba M
J Biol Chem; 2013 Jun; 288(25):18521-32. PubMed ID: 23658022
[TBL] [Abstract][Full Text] [Related]
7. Axonal targeting of the serotonin transporter in cultured rat dorsal raphe neurons is specified by SEC24C-dependent export from the endoplasmic reticulum.
Montgomery TR; Steinkellner T; Sucic S; Koban F; Schüchner S; Ogris E; Sitte HH; Freissmuth M
J Neurosci; 2014 Apr; 34(18):6344-6351. PubMed ID: 24790205
[TBL] [Abstract][Full Text] [Related]
8. The serotonin transporter is an exclusive client of the coat protein complex II (COPII) component SEC24C.
Sucic S; El-Kasaby A; Kudlacek O; Sarker S; Sitte HH; Marin P; Freissmuth M
J Biol Chem; 2011 May; 286(18):16482-90. PubMed ID: 21454670
[TBL] [Abstract][Full Text] [Related]
9. The activity and surface presence of organic cation/carnitine transporter OCTN2 (SLC22A5) in breast cancer cells depends on AKT kinase.
Papierniak-Wyglądała A; Lamch W; Jurewicz E; Nałęcz KA
Arch Biochem Biophys; 2023 Jul; 742():109616. PubMed ID: 37187422
[TBL] [Abstract][Full Text] [Related]
10. Blockade of the amino acid transporter SLC6A14 suppresses tumor growth in colorectal Cancer.
Lu Y; Jiang Z; Wang K; Yu S; Hao C; Ma Z; Fu X; Qin MQ; Xu Z; Fan L
BMC Cancer; 2022 Jul; 22(1):833. PubMed ID: 35907820
[TBL] [Abstract][Full Text] [Related]
11. SLC6A14 (ATB0,+) protein, a highly concentrative and broad specific amino acid transporter, is a novel and effective drug target for treatment of estrogen receptor-positive breast cancer.
Karunakaran S; Ramachandran S; Coothankandaswamy V; Elangovan S; Babu E; Periyasamy-Thandavan S; Gurav A; Gnanaprakasam JP; Singh N; Schoenlein PV; Prasad PD; Thangaraju M; Ganapathy V
J Biol Chem; 2011 Sep; 286(36):31830-8. PubMed ID: 21771784
[TBL] [Abstract][Full Text] [Related]
12. Switching the clientele: a lysine residing in the C terminus of the serotonin transporter specifies its preference for the coat protein complex II component SEC24C.
Sucic S; Koban F; El-Kasaby A; Kudlacek O; Stockner T; Sitte HH; Freissmuth M
J Biol Chem; 2013 Feb; 288(8):5330-41. PubMed ID: 23288844
[TBL] [Abstract][Full Text] [Related]
13. Deletion of the amino acid transporter Slc6a14 suppresses tumour growth in spontaneous mouse models of breast cancer.
Babu E; Bhutia YD; Ramachandran S; Gnanaprakasam JP; Prasad PD; Thangaraju M; Ganapathy V
Biochem J; 2015 Jul; 469(1):17-23. PubMed ID: 26173258
[TBL] [Abstract][Full Text] [Related]
14. Akt phosphorylates Sec24: new clues into the regulation of ER-to-Golgi trafficking.
Sharpe LJ; Luu W; Brown AJ
Traffic; 2011 Jan; 12(1):19-27. PubMed ID: 20950345
[TBL] [Abstract][Full Text] [Related]
15. Selective export of autotaxin from the endoplasmic reticulum.
Lyu L; Wang B; Xiong C; Zhang X; Zhang X; Zhang J
J Biol Chem; 2017 Apr; 292(17):7011-7022. PubMed ID: 28298439
[TBL] [Abstract][Full Text] [Related]
16. SLC6A14, a Pivotal Actor on Cancer Stage: When Function Meets Structure.
Palazzolo L; Paravicini C; Laurenzi T; Adobati S; Saporiti S; Guerrini U; Gianazza E; Indiveri C; Anderson CMH; Thwaites DT; Eberini I
SLAS Discov; 2019 Oct; 24(9):928-938. PubMed ID: 31373846
[TBL] [Abstract][Full Text] [Related]
17. Reshaping the Binding Pocket of the Neurotransmitter:Solute Symporter (NSS) Family Transporter SLC6A14 (ATB
Anderson CMH; Edwards N; Watson AK; Althaus M; Thwaites DT
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291613
[TBL] [Abstract][Full Text] [Related]
18. Amino acid transporter SLC6A14 is a novel and effective drug target for pancreatic cancer.
Coothankandaswamy V; Cao S; Xu Y; Prasad PD; Singh PK; Reynolds CP; Yang S; Ogura J; Ganapathy V; Bhutia YD
Br J Pharmacol; 2016 Dec; 173(23):3292-3306. PubMed ID: 27747870
[TBL] [Abstract][Full Text] [Related]
19. SLC6A14, a Na+/Cl--coupled amino acid transporter, functions as a tumor promoter in colon and is a target for Wnt signaling.
Sikder MOF; Sivaprakasam S; Brown TP; Thangaraju M; Bhutia YD; Ganapathy V
Biochem J; 2020 Apr; 477(8):1409-1425. PubMed ID: 32219372
[TBL] [Abstract][Full Text] [Related]
20. Interaction of tryptophan derivatives with SLC6A14 (ATB0,+) reveals the potential of the transporter as a drug target for cancer chemotherapy.
Karunakaran S; Umapathy NS; Thangaraju M; Hatanaka T; Itagaki S; Munn DH; Prasad PD; Ganapathy V
Biochem J; 2008 Sep; 414(3):343-55. PubMed ID: 18522536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
